SICHUAN KELUN-BIOTECH BIOPHARMACEUT financial statements, including revenue, expenses, profit, and loss

The total revenue of 6990 for the last semiannual is 1.50 B HKD, and it's 180.62% higher compared to the previous semiannual. The net income of H1 24 is 336.17 M HKD.